What is Teriflunomide?

Category: Prescription Drugs

Most popular types: Aubagio

false

Teriflunomide is thought to prevent the interaction of cells in the immune system involved in damage to the myelin sheath. It is used to treat relapsing-remitting Multiple Sclerosis.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Multiple sclerosis 2210 296
Participate in clinical trial 12 10
Balance problems 1 0
Infantile myofibromatosis 1 0
Numbness 1 0

Show all 9 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 45
Moderate 49
Mild 76
None 138

Commonly reported side effects and conditions associated with Teriflunomide

Side effect Patients Percentage
Hair loss 38
Diarrhea 22
Nausea 14
Hair thinning 12
Headaches 9
Elevated blood pressure 6

Show all 89 reported side effects

Why patients stopped taking Teriflunomide

Multiple reasons could be selected

Reason Patients Percentage
Side effects too severe 51
Did not seem to work 41
Doctor's advice 29
Other 14
Expense 4
Change in health plan coverage 3
Course of treatment ended 3
Personal research 3
See all 114 patients who've stopped taking Teriflunomide

Duration

Stopped taking Teriflunomide

Duration Patients Percentage
Less than 1 month 11
1 - 6 months 31
6 months - 1 year 22
1 - 2 years 21
2 - 5 years 27
5 - 10 years 4
10 years or more 1
Adherence
Adherence Evaluations Percentage
Always 278
Usually 16
Sometimes 2
Never taken as prescribed 12
Burden
Burden Evaluations Percentage
Very hard to take 7
Somewhat hard to take 11
A little hard to take 15
Not at all hard to take 275
Cost per month
Cost per month Evaluations Percentage
$200+ 20
$100-199 2
$50-99 8
$25-49 5
< $25 149
Not specified 124

What people switch to and from

Patients started taking Teriflunomide after stopping:

Treatment Patients Percentage
Dimethyl fumarate (Tecfidera) 66
Glatiramer acetate (Copaxone) 58
Interferon beta-1a IM Injection (Avonex) 31
Interferon beta-1a SubQ injection (Rebif) 21
Natalizumab (Tysabri) 20

Show all 17 treatments patients report switching from

Patients stopped taking Teriflunomide and switched to:

Treatment Patients Percentage
Ocrelizumab (Ocrevus) 23
Glatiramer acetate (Copaxone) 17
Dimethyl fumarate (Tecfidera) 15
Natalizumab (Tysabri) 15
Alemtuzumab (Lemtrada) 6

Show all 14 treatments patients report switching to

Last updated:

11 patient evaluations for Teriflunomide

Jan 15, 2019 (Started Jul 01, 2018)

  • Effectiveness
    Major (for multiple sclerosis)
  • Side effects
    Severe (liver impairment)
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 7 mg Daily
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Cost: < $25 monthly

Jan 6, 2019 (Started Jul 01, 2018)

  • Effectiveness
    Can't tell (for multiple sclerosis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 7 mg Daily
Cost: < $25 monthly

  • 0 helpful marks

Jan 17, 2018 (Started Jul 30, 2016)

  • Effectiveness
    Major (for multiple sclerosis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 14 mg Daily
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Cost: < $25 monthly

Sep 6, 2016 (Started Jul 30, 2016)

  • Effectiveness
    Can't tell (for multiple sclerosis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 14 mg Daily
Cost: < $25 monthly

  • 1 helpful mark

Dec 15, 2017 (Started Jan 15, 2016)

  • Effectiveness
    Moderate (for multiple sclerosis)
  • Side effects
    Severe (chronic eosinophilic pneumonia)
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 14 mg Daily

  • 0 helpful marks
Last updated:
Showing 3 of 11 patient evaluations for Teriflunomide